当前位置:主页 > 医学论文 > 中医论文 >

甜梦口服液治疗慢性阻塞性肺疾病伴失眠的临床观察

发布时间:2018-11-08 19:37
【摘要】:目的探讨甜梦口服液在慢性阻塞性肺疾病(COPD)伴失眠治疗中的临床疗效。方法将本院2013年2月—2015年2月收治的COPD合并失眠患者86例随机分为对照组和试验组,每组各43例。对照组采用常规治疗,试验组在对照组常规治疗基础上加服甜梦口服液治疗。治疗4周后,对比两组的临床疗效、生活质量,匹兹堡睡眠指数(PSQI)、睡眠效率、睡眠潜伏期、睡眠总时间、觉醒次数、觉醒总时间、肺功能。结果治疗后,对照组和试验组的总有效率分别为79.07%和93.02%,两组比较差异显著(P0.01)。治疗后,两组患者PSQI总分、睡眠潜伏期、觉醒次数、觉醒总时间、呼吸症状、活动受限均显著降低,睡眠效率、睡眠总时间、第1秒用力呼气容量(FEV1)、和FEV1/用力肺活量(FVC)均升高,同组治疗前后比较差异显著(P0.05);且试验组这些指标的改善程度优于对照组,差异显著(P0.05)。结论甜梦口服液可改善COPD伴失眠患者的睡眠质量,降低PSQI评分,具有一定的临床应用价值。
[Abstract]:Objective to investigate the clinical effect of Tianmeng oral liquid in the treatment of chronic obstructive pulmonary disease (COPD) with insomnia. Methods from February 2013 to February 2015, 86 patients with COPD complicated with insomnia were randomly divided into control group and experimental group with 43 cases in each group. The control group was treated with routine therapy, and the experimental group was treated with Tianmeng oral liquid on the basis of the control group's routine treatment. After 4 weeks of treatment, the clinical efficacy, quality of life, Pittsburgh sleep index (PSQI),) sleep efficiency, sleep latency, total sleep time, arousal times, total awakening time and lung function were compared between the two groups. Results after treatment, the total effective rates of the control group and the experimental group were 79.07% and 93.02%, respectively. The difference between the two groups was significant (P0.01). After treatment, the total PSQI score, sleep latency, arousal times, total arousal time, respiratory symptoms and restricted activities were significantly decreased, sleep efficiency, total sleep time, forced expiratory volume (FEV1) were significantly decreased in both groups. Compared with FEV1/ forced vital capacity (FVC) increased significantly in the same group before and after treatment (P0.05). The improvement of these indexes in the experimental group was better than that in the control group, and the difference was significant (P0.05). Conclusion Tianmeng oral liquid can improve the sleep quality of COPD patients with insomnia and decrease the PSQI score. It has certain clinical application value.
【作者单位】: 山东潍坊医学院附属益都中心医院保健综合老年病科;
【分类号】:R256.23;R259

【相似文献】

相关期刊论文 前10条

1 倪俊芝;;甜梦口服液辅助治疗抑郁症疗效观察[J];中草药;2007年07期

2 李爱云;;甜梦口服液治疗无症状性脑血管病患者焦虑状态的临床观察[J];中草药;2006年05期

3 丁文涛;;甜梦口服液治疗失眠伴阳痿症的临床观察[J];中国医药导报;2007年20期

4 王尚红;项春兰;何岩;张颖;;“甜梦口服液”治疗失眠的临床观察[J];中国民康医学;2008年01期

5 翟慕远,郭先敏,白念兰,崔英光;甜梦口服液治疗65例神经衰弱的疗效观察[J];甘肃中医学院学报;1998年01期

6 刘继芳;王洪华;;甜梦在神经科的临床应用[J];亚太传统医药;2006年12期

7 白雪歌;穆洪;张万祥;;甜梦口服液治疗冠脉搭桥术后患者焦虑抑郁的临床观察[J];中草药;2007年05期

8 曾艳芳;崔宏力;秦博文;;甜梦口服液治疗脑梗塞后焦虑症30例[J];中医杂志;2004年03期

9 黄质诚;;甜梦口服液与针灸联合治疗焦虑症临床观察[J];中草药;2007年04期

10 陈李华;陈欣童;万于军;林婉绢;王红;;甜梦口服液治疗更年期综合征疗效观察[J];现代中西医结合杂志;2008年04期

相关会议论文 前3条

1 宓思宽;胡晓峰;;甜梦治疗抑郁症的方药分析及临床研究[A];中国中西医结合学会第七届精神疾病学术讨论会论文汇编[C];2002年

2 刘继芳;;甜梦胶囊(口服液)在神经科的临床应用[A];第九次全国中西医结合虚证与老年病学术会议论文集[C];2007年

3 周正保;刘家林;;“甜梦口服液”治疗神经衰弱50例临床报告[A];第八次全国中西医结合精神疾病学术研讨会论文集[C];2005年



本文编号:2319460

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/2319460.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户a48e6***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com